Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00431080 | Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | completed | Phase 3 | 478 | Hellenic Oncology Research GroupOTHER | 1 | Jan 21, 2008 | clinicaltrials |
| NCT00080340 | Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 3 | 520 | TelikINDUSTRY | 8 | Jan 15, 2008 |
| NCT00591526 | A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL) | completed | Phase 3 | 250 | Groupe d'etude et de travail sur les leucemies aigues promyelocytairesOTHER | 0 | Jan 14, 2008 | clinicaltrials |
| NCT00040092 | A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer | completed | Phase 3 | 400 | Aptose Biosciences Inc.INDUSTRY | 0 | Jan 7, 2008 | clinicaltrials |
| NCT00234429 | A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma | completed | Phase 2 / Phase 3 | 74 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00252707 | Iressa 2nd Line Phase III Study in Japan | completed | Phase 3 | 484 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00575926 | Lingzhi for Cancer Children | completed | Phase 3 | 58 | Chinese University of Hong KongOTHER | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00127478 | A Long Term Safety Study With Atrasentan | completed | Phase 2 / Phase 3 | 166 | AbbottINDUSTRY | 5 | Nov 29, 2007 | clinicaltrials |
| NCT00128531 | Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer | completed | Phase 3 | 120 | GP-PharmINDUSTRY | 9 | Nov 14, 2007 | clinicaltrials |
| NCT00190710 | A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer | completed | Phase 3 | 242 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00535912 | Phase III Study Treatment of CLL B and C | completed | Phase 3 | 140 | French Innovative Leukemia OrganisationOTHER | 0 | Nov 1, 2007 | clinicaltrials |
| NCT00536393 | Treatment of Disseminated High Grade Lymphoma | completed | Phase 2 / Phase 3 | 100 | French Innovative Leukemia OrganisationOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00536458 | Treatment of Localized Low Grade Lymphomas | completed | Phase 3 | 132 | French Innovative Leukemia OrganisationOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00548600 | Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate | completed | Phase 3 | 112 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 24, 2007 | clinicaltrials |
| NCT00201942 | PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | completed | Phase 3 | 336 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 18, 2007 | clinicaltrials |
| NCT00421694 | Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide | completed | Phase 2 / Phase 3 | 119 | University of L'AquilaOTHER | 1 | Oct 8, 2007 | clinicaltrials |
| NCT00539630 | TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN | completed | Phase 3 | 86 | SanofiINDUSTRY | 1 | Oct 4, 2007 | clinicaltrials |
| NCT00142571 | Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma | completed | Phase 3 | 120 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 2, 2007 | clinicaltrials |
| NCT00001561 | Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation | completed | Phase 3 | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 24, 2007 | clinicaltrials |
| NCT00529412 | Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction | completed | Phase 3 | 150 | Nihon UniversityOTHER | 1 | Sep 14, 2007 | clinicaltrials |
| NCT00294359 | The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer | completed | Phase 2 / Phase 3 | 333 | Australasian Gastro-Intestinal Trials GroupNETWORK | 2 | Aug 22, 2007 | clinicaltrials |
| NCT00514488 | Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)(CML022) | completed | Phase 3 | — | University of BolognaOTHER | 1 | Aug 10, 2007 | clinicaltrials |
| NCT00145652 | Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. | completed | Phase 3 | 66 | Sundsvall HospitalOTHER | 1 | Jul 30, 2007 | clinicaltrials |
| NCT00169130 | ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma | completed | Phase 2 / Phase 3 | 300 | Lymphoma Study AssociationOTHER | 2 | Jul 13, 2007 | clinicaltrials |
| NCT00136552 | Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden | completed | Phase 3 | 360 | Lymphoma Study AssociationOTHER | 2 | Jul 3, 2007 | clinicaltrials |
| NCT00201929 | A Decision Aid for Women With Early Stage Breast Cancer | completed | Phase 3 | 300 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00494546 | High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer | completed | Phase 3 | 568 | VA Puget Sound Health Care SystemFED | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00344526 | Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis | completed | Phase 3 | 100 | University Hospital, LimogesOTHER | 1 | Jun 28, 2007 | clinicaltrials |
| NCT00483132 | Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III | completed | Phase 3 | 232 | French Innovative Leukemia OrganisationOTHER | 1 | Jun 6, 2007 | clinicaltrials |
| NCT00480064 | Lomustine and Intermediate Dose Cytarabine in Older Patients With AML | completed | Phase 3 | 360 | French Innovative Leukemia OrganisationOTHER | 1 | May 30, 2007 | clinicaltrials |
| NCT00114816 | Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer | completed | Phase 3 | 1,500 | Finnish Breast Cancer GroupOTHER | 1 | May 21, 2007 | clinicaltrials |
| NCT00054795 | Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) | completed | Phase 3 | 550 | Pharmacyclics LLC.INDUSTRY | 8 | May 8, 2007 | clinicaltrials |
| NCT00039910 | Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia | completed | Phase 3 | 240 | PfizerINDUSTRY | 8 | May 4, 2007 | clinicaltrials |
| NCT00467948 | Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients | completed | Phase 3 | 90 | Tehran University of Medical SciencesOTHER | 1 | May 1, 2007 | clinicaltrials |
| NCT00430911 | Radiotherapy for Malignant Astrocytomas in the Elderly | completed | Phase 3 | — | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 2, 2007 | clinicaltrials |
| NCT00190762 | A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma | completed | Phase 3 | 240 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00376883 | Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month | completed | Phase 3 | 500 | Nordic Myeloma Study GroupOTHER | 3 | Jan 4, 2007 | clinicaltrials |
| NCT00102414 | Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer | completed | Phase 3 | 356 | AGO Study GroupOTHER | 0 | Nov 14, 2006 | clinicaltrials |
| NCT00037791 | Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia | completed | Phase 3 | 180 | PfizerINDUSTRY | 3 | Nov 9, 2006 | clinicaltrials |
| NCT00161980 | Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites | completed | Phase 3 | — | Baxter Healthcare CorporationINDUSTRY | 4 | Oct 23, 2006 | clinicaltrials |
| NCT00300664 | A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. | completed | Phase 2 / Phase 3 | 150 | Royal Marsden NHS Foundation TrustOTHER | 0 | Oct 13, 2006 | clinicaltrials |
| NCT00359060 | Physical Activity and Breast Cancer Risk in Postmenopausal Women:the SHAPE Study | completed | Phase 3 | 180 | UMC UtrechtOTHER | 1 | Oct 13, 2006 | clinicaltrials |
| NCT00386984 | Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma | completed | Phase 3 | 108 | University Hospital FreiburgOTHER | 1 | Oct 12, 2006 | clinicaltrials |
| NCT00378222 | Autologous Transplantation for Multiple Myeloma | completed | Phase 3 | 324 | University of BolognaOTHER | 0 | Sep 19, 2006 | clinicaltrials |
| NCT00272051 | XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy | completed | Phase 3 | 620 | SanofiINDUSTRY | 0 | Sep 13, 2006 | clinicaltrials |
| NCT00367185 | Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma | completed | Phase 3 | 500 | University Hospital, LilleOTHER | 1 | Aug 22, 2006 | clinicaltrials |
| NCT00036543 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 1,000 | AbbottINDUSTRY | 18 | Aug 15, 2006 | clinicaltrials |
| NCT00102375 | Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer | completed | Phase 3 | 900 | AGO Study GroupOTHER | 1 | Aug 4, 2006 | clinicaltrials |
| NCT00034268 | A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 21 | Jul 19, 2006 | clinicaltrials |
| NCT00352404 | Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia | completed | Phase 3 | 114 | Johannes Gutenberg University MainzOTHER | 1 | Jul 14, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Jan 21, 2008source: clinicaltrials